Bristol-Myers Squibb
BMY
BMY
1,312 hedge funds and large institutions have $61.7B invested in Bristol-Myers Squibb in 2013 Q4 according to their latest regulatory filings, with 179 funds opening new positions, 389 increasing their positions, 567 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,312
Holders Change
+125
Holders Change %
+10.53%
% of All Funds
38.11%
Holding in Top 10
65
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+27.45%
% of All Funds
1.89%
New
179
Increased
389
Reduced
567
Closed
39
Calls
$776M
Puts
$870M
Net Calls
-$94.3M
Net Calls Change
-$121M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$766M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$454M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$400M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$328M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$326M |
